6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Latest Press Releases

Time	Headline
Just now	Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain
Just now	Syntec Optics (Nasdaq: OPTX) Announces Pricing of $20 Million Underwritten Public Offering of Common Stock
Just now	Woodside Energy First Quarter Report for Period Ended 31 March 2026
Just now	InnoCare Announces First Patient Dosed in Phase III Trial of Orelabrutinib for SLE
27m ago	Jyong Biotech Updates Market Access Strategy for Innovative Botanical Drugs, Establishing Multiple Competitive Advantages for New Drug Portfolio

About

Inmed Pharmaceuticals Inc (NASDAQ:INM) — investor relations, events, news, and company updates on 6ix.

Latest News

InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance

InMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 Alzheimer's Disease Program

InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial

InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline

InMed Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update

Financials

Revenue

$4.51 M

Market Cap

$2.13 M

EPS

-2.87

Community Chat

Ask AI